x Acta Scientific | International Open Library | Open Access Journals Publishing Group

Acta Scientific Pharmaceutical Sciences (ASPS)(ISSN: 2581-5423)

Research Article Volume 4 Issue 10

Assessment of Treatment Outcomes and Associated Factors of Pneumonia among Hospitalized Pediatric Patients at Pediatric Ward in Jimma University Medical Center

Balcha Worku and Anbessa Bekele*

Pharmacy School, Health Institute, Jimma University, Ethiopia

*Corresponding Author: Anbessa Bekele, Pharmacy School, Health Institute, Jimma University, Ethiopia.

Received: July 27, 2020; Published: September 28, 2020



Background: Pneumonia and other lower respiratory tract infections are the leading causes of death worldwide. Because pneumonia is common and is associated with significant morbidity and mortality, properly diagnosing pneumonia, correctly recognizing any complications or underlying conditions, and appropriately treating patients are important. Although in developed countries the diagnosis is usually made in the basis of radiographic findings, the World health organization (WHO) has defined pneumonia solely on the basis of clinical findings obtained by visual inspection and on timing of the respiratory rate.

Pneumonia may originate in the lung or may be a focal complication of a contagious or systemic inflammatory process. Abnormalities of airway patency as well as alveolar ventilation and perfusion occur frequently due to various mechanisms. These derangements often significantly alter gas exchange and cellular metabolism in many tissues and organs that determine survival and contribute to quality of life. Recognition, prevention and treatment of this problems are major factors in the care of children with pneumonia.

Objective: The general objective of the study is to assess the treatment outcomes and associated factors of pneumonia among hospitalized pediatric patients at JUMC.

Methods: A hospital based retrospective cross sectional study was conducted to assess treatment outcomes and associated factors of pneumonia among hospitalized pediatric patients at JUMC.

Result: A total of 112 charts were reviewed, male comprised 65 of the study population. Majority, 62 of them were in the age range of 1 month - <1 years old. Majority, 61, of the patient’s weight were in the range of 6-10.9 kg.

Conclusion and Recommendation: the results of this study showed that high prevalence of Good treatment outcome in the study area. Patients who stayed >= 8 days were the significant predictors of poor treatment outcome in children with pneumonia.

Keywords: Pneumonia; Pediatrics; JUMC; Treatment Outcome



  1. Mario Venditti., et al. “Outcomes of Patients Hospitalize With Community-Acquired, Health Care Associated, and Hospital Acquired Pneumonia”. Annals of Internal Medicine 150 (2009): 19-26.
  2. Massimiliano Don., et al. “Prediction of delayed recovery from pediatric community-acquired pneumonia”. Italian Journal of Pediatrics 36 (2010): 51.
  3. Fauci Braunwald., et al. Harrison's pricinple's of Internal Medicine: Pneumonia. 17th edn. USA: McGraw-Hill Companies.
  4. British Thoracic Society Standards of Care Committee. “British Thoracic Society guidelines for the management of community acquired pneumonia in childhood”. Thorax 57  (2002):  1-24.
  5. Hailemariam Legesse and AssayeKassie. CCM technical working group, Community Case Management (CCM) of Pneumonia in children by health extension workers in rural communities following a policy change in Ethiopia 6.6(2020).
  6. Principi N and Esposito S. “Mycoplasma pneumoniae and Chlamydia pneumoniae cause lower respiratory tract disease in paediatric patients”. Current Opinion in Infectious Diseases 15 (2002): 295-300.
  7. Redd SC., et al. “Clinical signs of pneumonia in children attending a hospital outpatient department in Lesotho”. Bulletin of the World Health Organization 72 (1994): 113-118.
  8. American Family Physician 2004 70:899-908.Copyright© American Academy of Family Physicians (2004).
  9. Juven T., et al. “Etiology of community acquired pneumonia in 254 hospitalize children”. Pediatric Infectious Disease Journal 19 (2000): 293-298.
  10. Global Burdon of disease: Causes of death in neonates and children under five in the African region (2008).
  11. McIntosh K. “Community-acquired pneumonia”. The New England Journal of Medicine 346 (2002): 429-437.
  12. “Guidelines for the management of community-acquired pneumonia in childhood”. Thorax 57 (2002): 124.
  13. Mandell LA., et al. “Infectious Diseases Society of America American Thoracic Society: Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults”. Clinical Infectious Disease 44(2007): 27-72.
  14. Lassi ZS., et al. “Systematic review on antibiotic therapy for pneumonia in children less than 59 months of age”. Archives of Diseases in Childhood 99(2014):68793.
  15. WHO guideline for treatment of pneumonia (2014).
  16. Ruuskanen O Lahti., et al. “Viral pneumonia”. Lancet9773(2011): 1264-1275.
  17. Singh V., et al. “Pneumonia - management in the developing world”. Pediatric Respiratory Reviews 12 (2004): 529.
  18. , et al. “Epidemiology and etiology of childhood pneumonia”. Bulletin of the World Health Organization 86.5 (2008): 40816.
  19. Lopez-Gonzalez L., et al. “Characteristics of Medicaid and Uninsured Hospitalizations, 2012”. HCUP Statistical Brief #183. Rockville, MD: Agency for Healthcare Research and Quality (2014).
  20. Laura M., et al. Approach to Community-Acquired Pneumonia in Children Rappaport.
  21. WHO/UNICEF: Management of the child with a serious infection or severe Malnutrition. “Guidelines for care at the first-referral level in developing Countries”. WHO/FCH/CAH/001. Geneva, World Health Organization (2000).
  22. Decaillet F., et al. World Bank/AFTH3 (2003).
  23. Gedefaw Abeje Fekadu., et al. “Prevalence of Pneumonia among under- five Children in Este Town and the Surrounding Rural Kebeles, Northwest Ethiopia A Community Based Cross Sectional Study”. Science Journal of Public Health3(2014): 150-155.
  24. Peter Forsberg, medical student at the Sahlgrenska Academy at Gothenburg University, Sweden (2012).
  25. Black SB., et al. “Effectiveness of heptavalent pneumococcal conjugate vaccine in children younger than five years of age for prevention of pneumonia”. Pediatric Infectious Disease Journal 21(2002):8105.
  26. Federal Ministry of Health, Family health department. National strategy for child survival in Ethiopia. Addis Ababa, Ethiopia (2005)
  27. Cincinnati children's Hospital Medical center. “Evidence-based clinical practice guidelines of community acquired pneumonia in 60days to 17years of age”. Cincinnati, OH: Cincinnati Children‘s Hospital Medical Center (2000): 1-11.
  28. Rudan I., et al. “Global estimate of the incidence of clinical pneumonia among children under five years of age”. Bulletin of the World Health Organ 82(2004):895903.
  29. Bryce J., et al. “WHO estimates of the causes of death in children”. Lancet 365(2005):114752.
  30. Tan TQ., et al. “Clinical characteristics and outcome of children with pneumonia attributable to penicillinsusceptible and penicillin-nonsusceptible Streptococcus pneumoniae”.
  31. Karalanglin Tiewsoh., et al. “Factors determining the outcome of children hospitalized with Severe pneumonia”. BMC Paediatrics 23(2009):3-4.
  32. Iranian Journal of Pediatrics Society1 (2007): 36-40.
  33. Imane Jroundi., et al. “Risk factors for a poor outcome among children admitted with clinically severe pneumonia to a university hospital in Rabat, Morocco”. International Journal of Infectious Diseases (2014): 164-170.
  34. Peter Forsberg, medical student at the Sahlgrenska Academy at Gothenburg University, Sweden (2012).
  35. , et al. “Clinical treatment outcomes of pneumonia among hospitalized pediatric patients in Nekemte Referral Hospital, pediatrics ward, Ethiopia”. World Journal of Pharmacy and Pharmaceutical Sciences 6.2(2016): 68-84.
  36. McMullan BJ., et al. “Antibiotic duration and timing of the switch from intravenous to oral route for bacterial infections in children: systematic review and guidelines”. Lancet Infection Disease8(2016):e139-152.
  37. Harris M., et al. “British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011”. Thorax 66(2011):ii1-23.
  38. Le Saux N., et al. “Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management”. Paediatric Child Health 8(2015):441-445.


Citation: Balcha Worku and Anbessa Bekele. “Assessment of Treatment Outcomes and Associated Factors of Pneumonia among Hospitalized Pediatric Patients at Pediatric Ward in Jimma University Medical Center". Acta Scientific Pharmaceutical Sciences 4.10 (2020): 79-90.


Acceptance rate32%
Acceptance to publication20-30 days
Impact Factor0.759

Indexed In

News and Events

  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is April 30, 2021.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US